Medicine and Dentistry
Tumor Cell
85%
Metastatic Carcinoma
65%
Kidney Transplantation
64%
Cytokeratin
59%
Liver Transplantation
54%
Neoplasm
47%
Prognostic Factor
40%
Kidney Graft
40%
Malignant Neoplasm
39%
Multivariate Analysis
37%
Diseases
35%
Epithelioma
31%
Cancer Staging
31%
Carcinoma
30%
Lymph Node
29%
Monoclonal Antibody
29%
Pancreas Carcinoma
29%
Epithelial Cell
28%
Reperfusion Injury
27%
Low Drug Dose
24%
Immunosuppressive Treatment
23%
Nitric Oxide
23%
Pancreas Cancer
23%
Tacrolimus
23%
Gastrointestinal Cancer
21%
Kidney Pancreas Transplantation
21%
Liver Graft
18%
Aminoguanidine
17%
Alkaline Phosphatase
16%
Cytomegalovirus
16%
Micrometastasis
15%
Infection
15%
Overall Survival
15%
Distant Metastasis
14%
Primary Tumor
14%
Abdominal Cancer
13%
Minimal Residual Disease
13%
Clinical Significance
12%
Ureter
12%
Esophageal Cancer
12%
Mortality Rate
12%
Retransplantation
12%
Liver Metastasis
12%
Carcinoma Cell
12%
Esophagus Carcinoma
12%
Acetylsalicylic Acid
11%
Adjuvant Therapy
11%
Mononuclear Cell
11%
Ischemia
10%
Density Gradient Centrifugation
10%
Keyphrases
Bone Marrow
100%
Liver Transplantation
61%
Tumor Cells
47%
Cytokeratin
42%
Disseminated Tumor Cells
42%
Prognostic Factors
40%
Multivariate Analysis
38%
Cancer Patients
35%
Epithelial Tumor Cells
31%
Kidney
31%
Transplantation
29%
Kidney Transplant Recipients
29%
Kidney Transplantation
27%
Epithelial Cells
26%
Ischemia-reperfusion Injury
26%
Pancreatic Carcinoma
25%
Living Donor Kidney Transplantation
23%
High Risk
23%
Resection
22%
Lymph Node
22%
Tacrolimus
21%
Rat Model
21%
Monoclonal Antibody
20%
Gastrointestinal Cancer
19%
Eurotransplant
19%
Esophageal Cancer
19%
Carcinoma
19%
Pancreatic Cancer
18%
FK506
17%
Aminoguanidine
17%
Cytomegalovirus
16%
Micrometastasis
15%
Nitric Oxide Inhibitor
15%
Graft Preconditioning
15%
Immunosuppression
15%
Clinical Significance
14%
Renal Transplantation
14%
Tumor
14%
Simultaneous Pancreas-kidney Transplantation
13%
R0 Resection
13%
Ureter
12%
Allogeneic
12%
Bone Marrow Aspirate
12%
Retransplantation
12%
Graft Function
12%
Liver Metastasis
12%
Minimal Residual Disease
12%
Immunosuppressive Therapy
12%
Calcineurin Inhibitors
11%
Gastrointestinal Side Effects
11%